Dose-dependent improvement of myoclonic hyperkinesia due to Valproic acid in eight Huntington's Disease patients: a case series
2006

Valproic Acid Improves Myoclonic Hyperkinesia in Huntington's Disease

Sample size: 8 publication Evidence: moderate

Author Information

Author(s): Carsten Saft, Thorsten Lauter, Peter H Kraus, Horst Przuntek, Juergen E Andrich

Primary Institution: Department of Neurology, Huntington-Center NRW, St. Josef Hospital, Bochum, Germany

Hypothesis

Can valproic acid improve myoclonic hyperkinesia in patients with Huntington's Disease?

Conclusion

Valproic acid may be an effective alternative treatment for Huntington's Disease patients suffering from myoclonic hyperkinesia.

Supporting Evidence

  • Seven out of eight patients showed improvement in myoclonic hyperkinesia after treatment with valproic acid.
  • The UHDRS motor score improved from an initial mean of 73.1 to 60.2 after treatment.
  • In three patients, the dosage of antidopaminergic medication could be reduced.

Takeaway

This study shows that valproic acid can help people with Huntington's Disease who have jerky movements, making it easier for them to move.

Methodology

Eight patients with myoclonic hyperkinesia were treated with valproic acid and assessed using the Unified Huntington's Disease Rating Scale (UHDRS) motor score before and after treatment.

Limitations

The study is limited by the small sample size and lack of a control group.

Participant Demographics

All participants were adult patients with Huntington's Disease, primarily exhibiting myoclonic hyperkinesia.

Statistical Information

P-Value

0.042

Statistical Significance

p = 0.042

Digital Object Identifier (DOI)

10.1186/1471-2377-6-11

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication